MedTrace Logo

Therapeutic Variables in Cataract Surgery

NCT00407017 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2007-08-21

No results posted yet for this study

Summary

The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.

Conditions

  • Cataract Surgery

Interventions

DRUG

Gatifloxacin

DRUG

Ketorolac LS

DRUG

Pred Forte

DRUG

Moxifloxacin

DRUG

Nepafenac

DRUG

EconoPred Plus

Sponsors & Collaborators

  • Innovative Medical

    lead INDUSTRY

Principal Investigators

  • William Trattler, MD · The Center For Excellence in Eye Care

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00407017 on ClinicalTrials.gov